Holders — by stockHoldings — by fund
Tri Locum Partners LP
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001826434
$506.1M
disclosed book value
18
positions
13.7%
largest position share
Positions, as of 2026-09-30
top 18 of 18 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | VRTXVERTEX PHARMACEUTICALS INC | 132,896 | $69.5M | 13.7% |
| 2 | LLYELI LILLY & CO | 51,015 | $59.0M | 11.7% |
| 3 | TEVATEVA PHARMACEUTICAL INDS LTD | 1.2M | $48.5M | 9.6% |
| 4 | AMRXAMNEAL PHARMACEUTICALS INC | 2.3M | $46.9M | 9.3% |
| 5 | DXCMDEXCOM INC | 489,400 | $42.2M | 8.3% |
| 6 | JAZZJAZZ PHARMACEUTICALS PLC | 160,321 | $37.1M | 7.3% |
| 7 | ARGXARGENX SE | 30,399 | $29.1M | 5.8% |
| 8 | ASNDASCENDIS PHARMA A/S | 118,384 | $27.0M | 5.3% |
| 9 | AXSMAXSOME THERAPEUTICS INC. | 143,338 | $26.4M | 5.2% |
| 10 | JNJJOHNSON & JOHNSON | 73,559 | $19.5M | 3.8% |
| 11 | ELVNENLIVEN THERAPEUTICS INC | 410,236 | $18.8M | 3.7% |
| 12 | UTHRUNITED THERAPEUTICS CORP DEL | 33,000 | $17.9M | 3.5% |
| 13 | MDGLMADRIGAL PHARMACEUTICALS INC | 33,668 | $17.0M | 3.4% |
| 14 | CELCCELCUITY INC | 202,618 | $16.1M | 3.2% |
| 15 | DNTHDIANTHUS THERAPEUTICS INC | 177,225 | $15.6M | 3.1% |
| 16 | RVMDREVOLUTION MEDICINES INC | 40,019 | $8.2M | 1.6% |
| 17 | DFTXDEFINIUM THERAPEUTICS INC | 144,406 | $5.5M | 1.1% |
| 18 | VRDNVIRIDIAN THERAPEUTICS INC | 90,107 | $1.9M | 0.4% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.